Related Experiment Video

Updated: Jul 19, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Chronic liver disease prevention strategies and liver transplantation

Anderson Soares da Silva1, Luciane Loures dos Santos, Afonso Dinis Costa Passos

  • 1Department of Social Medicine, FMRP, USP, Brazil.

Acta Cirurgica Brasileira
|October 3, 2006
PubMed

Insights

Chronic liver disease, primarily caused by alcohol and viral hepatitis, leads to cirrhosis. Preventive strategies, including Hepatitis B vaccination, are crucial to avoid severe outcomes and reduce public health burdens.

Area of Science:

  • Hepatology
  • Public Health
  • Preventive Medicine

Background:

  • Chronic liver disease represents a significant global health issue, particularly in Africa and Asia.
  • Cirrhosis, the end stage of chronic liver disease, necessitates liver transplantation as the sole treatment.
  • Alcohol abuse and viral hepatitis are leading preventable causes of end-stage liver disease.

Purpose of the Study:

  • To review the preventable etiologies of cirrhosis.
  • To discuss preventive strategies for cirrhosis and its severe consequences.
  • To highlight the public health impact of alcohol consumption and viral hepatitis.

Main Methods:

  • Literature review focusing on causes and prevention of cirrhosis.
  • Analysis of epidemiological data on chronic liver disease.
  • Synthesis of information on alcohol-related liver disease and viral hepatitis (Hepatitis B and C).

Main Results:

  • Excessive alcohol consumption and viral hepatitis (Hepatitis B and C) account for 70-80% of end-stage liver diseases globally.
  • Hepatitis B is preventable through an available vaccine.
  • Hepatitis C, while lacking a vaccine, can be managed through preventive measures.

Conclusions:

  • Implementing preventive strategies for alcohol abuse and viral hepatitis is essential to reduce the incidence of cirrhosis.
  • Widespread use of the Hepatitis B vaccine is recommended.
  • Continued efforts are needed to prevent Hepatitis C transmission while awaiting a vaccine.

More Related Videos

Extended 78% Hepatectomy in a Mouse Surgical Model05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...